COMPANY
Ambergen
Service / Tools company
NIH awards 50
- NIH award 5R44AG078097-02 FY2023: $1,081,032 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Photocleavable Mass-Tags for Spatial Multiomics of Alz source ↗
- NIH award 5R44AI165129-02 FY2023: $978,625 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. New Technology for High-Resolution Antibody Profiling fo source ↗
- NIH award 5R44MH132196-02 FY2023: $910,446 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. A Highly Multiplexed, Multiomic 3D Mouse Brain Map Using source ↗
- NIH award 1R44MH132196-01 FY2022: $1,084,108 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. A Highly Multiplexed, Multiomic 3D Mouse Brain Map Usi source ↗
- NIH award 1R44AI165129-01A1 FY2022: $978,625 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. New Technology for High-Resolution Antibody Profiling source ↗
- NIH award 1R44AG078097-01 FY2022: $1,354,952 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Photocleavable Mass-Tags for Spatial Multiomics of Alz source ↗
- NIH award 5R44AG067866-02 FY2021: $1,249,958 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Photocleavage Technology for Blood-based Multi-Biomark source ↗
- NIH award 5R44CA236097-03 FY2020: $999,744 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Highly Multiplexed Nanoscale Mass Spectrometric Imaging source ↗
- NIH award 1R44AG067866-01 FY2020: $1,249,958 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Photocleavage Technology for Blood-based Multi-Biomark source ↗
- NIH award 2R44CA236097-02 FY2019: $999,744 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Highly Multiplexed Nanoscale Mass Spectrometric Imaging source ↗
- NIH award 5R44AI100424-07 FY2019: $1,000,000 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Multiplexed Bead-based In Vitro Pediatric Allergy Test source ↗
- NIH award 1R43CA236097-01 FY2018: $300,000 awarded for that fiscal year; activity R43 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Highly Multiplexed Nanoscale Mass Spectrometric Imaging source ↗
- NIH award 5R44GM105249-05 FY2018: $753,500 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Mass Spectrometric Bead-Imaging of Off-Target Drug Inter source ↗
- NIH award 2R44AI100424-06 FY2018: $937,987 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Multiplexed Bead-based In Vitro Pediatric Allergy Test source ↗
- NIH award 5R44GM105249-04 FY2017: $753,500 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Mass Spectrometric Bead-Imaging of Off-Target Drug Inter source ↗
- NIH award 2R44GM105249-03 FY2016: $753,500 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Mass Spectrometric Bead-Imaging of Off-Target Drug Inter source ↗
- NIH award 1R43CA203647-01A1 FY2016: $225,000 awarded for that fiscal year; activity R43 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Photocleavage Technology for Improved Serum-based Mult source ↗
- NIH award 5R44AI100424-05 FY2016: $998,905 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Multiplexed Bead-based In Vitro Pediatric Allergy Test source ↗
- NIH award 5R44CA161965-04 FY2015: $499,744 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Global Proteomic Screening by MALDI Spectrometric Imagin source ↗
- NIH award 5R44AI100424-04 FY2015: $998,905 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Multiplexed Bead-based In Vitro Pediatric Allergy Test source ↗
- NIH award 2R44CA161965-03 FY2014: $499,745 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Global Proteomic Screening by MALDI Spectrometric Imagin source ↗
- NIH award 5R44CA137948-04 FY2014: $487,788 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Proteome Bead-Display for Discovery of Tumor Antigens source ↗
- NIH award 2R44AI100424-03 FY2014: $998,905 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Multiplexed Bead-based In Vitro Pediatric Allergy Test source ↗
- NIH award 5R43GM105249-02 FY2013: $349,212 awarded for that fiscal year; activity R43 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Photocleavable Bead Technology for Glycomics source ↗
- NIH award 5R44CA137948-03 FY2013: $487,788 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Proteome Bead-Display for Discovery of Tumor Antigens source ↗
- NIH award 5R43AI100424-02 FY2013: $298,459 awarded for that fiscal year; activity R43 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Multiplexed Bead-based In Vitro Pediatric Allergy Test source ↗
- NIH award 1R43GM105249-01 FY2012: $349,212 awarded for that fiscal year; activity R43 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Photocleavable Bead Technology for Glycomics source ↗
- NIH award 5R44CA119565-07 FY2012: $999,610 awarded for that fiscal year; activity R44 (SBIR); PI SEARS, CHRISTOPHER; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Expression-Based Multi-Gene Signatures for CRC source ↗
- NIH award 5R43CA161965-02 FY2012: $149,865 awarded for that fiscal year; activity R43 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Global Proteomic Screening by MALDI Spectrometric Imagin source ↗
- NIH award 2R44CA137948-02A1 FY2012: $487,788 awarded for that fiscal year; activity R44 (SBIR); PI LIM, MARK; recipient as written: AMBERGEN, INC, WATERTOWN, MA. Proteome Bead-Display for Discovery of Tumor Antigens source ↗